Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Consolidated Net Income: 2010-2024

Historic Consolidated Net Income for CorMedix (CRMD) over the last 15 years, with Dec 2024 value amounting to -$17.9 million.

  • CorMedix's Consolidated Net Income rose 4002.28% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.0 million, marking a year-over-year increase of 496.27%. This contributed to the annual value of -$17.9 million for FY2024, which is 62.52% up from last year.
  • As of FY2024, CorMedix's Consolidated Net Income stood at -$17.9 million, which was up 62.52% from -$47.8 million recorded in FY2023.
  • CorMedix's 5-year Consolidated Net Income high stood at -$17.9 million for FY2024, and its period low was -$47.8 million during FY2023.
  • Moreover, its 3-year median value for Consolidated Net Income was -$29.7 million (2022), whereas its average is -$31.8 million.
  • As far as peak fluctuations go, CorMedix's Consolidated Net Income tumbled by 61.07% in 2023, and later surged by 62.52% in 2024.
  • Yearly analysis of 5 years shows CorMedix's Consolidated Net Income stood at -$22.0 million in 2020, then fell by 28.07% to -$28.2 million in 2021, then declined by 5.29% to -$29.7 million in 2022, then tumbled by 61.07% to -$47.8 million in 2023, then spiked by 62.52% to -$17.9 million in 2024.